Nu Skin Enterprises (NYSE:NUS) Lowered to Buy Rating by Wall Street Zen

Key Points

• Nu Skin Enterprises has been downgraded by Wall Street Zen from a "strong-buy" to a "buy" rating, indicating a shift in analyst sentiment regarding the stock's performance.
• The company's stock experienced a decline of 6.9%, with current trading at $11.46 and a 52-week range between $5.32 and $12.40.
• Despite the downgrade, Nu Skin reported earnings of $0.43 per share for the last quarter, surpassing consensus expectations of $0.25.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report issued on Friday.

Separately, Zacks Research upgraded Nu Skin Enterprises to a "hold" rating in a research report on Tuesday, August 12th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $6.88.

Nu Skin Enterprises Price Performance

Nu Skin Enterprises stock traded up $0.20 during midday trading on Friday, reaching $11.72. 616,161 shares of the stock traded hands, compared to its average volume of 516,453. Nu Skin Enterprises has a 12 month low of $5.32 and a 12 month high of $12.40. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The stock's fifty day moving average is $10.19 and its 200-day moving average is $8.27. The stock has a market cap of $580.14 million, a P/E ratio of 5.83 and a beta of 0.92.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.18. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%.The business had revenue of $386.14 million for the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, equities research analysts anticipate that Nu Skin Enterprises will post 1.05 EPS for the current year.

Insiders Place Their Bets

In other Nu Skin Enterprises news, Director Daniel W. Campbell sold 23,391 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $12.10, for a total transaction of $283,031.10. Following the sale, the director owned 53,375 shares of the company's stock, valued at approximately $645,837.50. This trade represents a 30.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Laura Nathanson sold 6,489 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $12.22, for a total value of $79,295.58. Following the sale, the director directly owned 33,149 shares in the company, valued at $405,080.78. This trade represents a 16.37% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 58,926 shares of company stock worth $711,364 in the last ninety days. 2.00% of the stock is owned by company insiders.

Institutional Trading of Nu Skin Enterprises

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Two Sigma Investments LP boosted its position in Nu Skin Enterprises by 24.2% during the 4th quarter. Two Sigma Investments LP now owns 700,500 shares of the company's stock valued at $4,826,000 after acquiring an additional 136,624 shares in the last quarter. Man Group plc boosted its position in Nu Skin Enterprises by 125.5% during the 4th quarter. Man Group plc now owns 102,836 shares of the company's stock valued at $709,000 after acquiring an additional 57,235 shares in the last quarter. New York State Teachers Retirement System bought a new stake in Nu Skin Enterprises during the 1st quarter valued at $33,000. Wealth Enhancement Advisory Services LLC bought a new stake in Nu Skin Enterprises during the 1st quarter valued at $118,000. Finally, Hsbc Holdings PLC bought a new stake in Nu Skin Enterprises during the 1st quarter valued at $619,000. Institutional investors own 82.84% of the company's stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.